Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission, Transgenomic said it plans to offer up to $3.5 million in common stock for sale on the Nasdaq and other trading markets.

Banking firm Craig-Hallum Capital Group will serve as sales manager, and will receive a commission of 3.25 percent based on the gross sales price, Transgenomic added. The shares will be offered at the prevailing market price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.